ReviewFrontiers in cell and developmental biology2026
Bisphenol A and ovarian cancer: emerging evidence and potential biological mechanisms.
Review in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review summarizes current evidence concerning the relationship between bisphenol A (BPA) exposure and ovarian cancer (OC). Human epidemiological studies have mainly examined possible associations between BPA concentrations and OC occurrence, but their cross-sectional or case-control designs do not establish that BPA exposure increases OC risk. Experimental studies in OC cell lines and tumor-bearing animals suggest that BPA may alter tumor-related phenotypes, including proliferation, migration, invasion, angiogenesis, and stemness. These findings concern potential tumor progression rather than patient prognosis. Separate studies in normal ovarian tissue and granulosa cells indicate possible ovarian toxicity, including oxidative stress, apoptosis, and steroidogenic disturbances, but these findings should not be interpreted as direct evidence of OC risk. Mechanistically, BPA exposure has been reported to be associated with changes in endocrine signaling, oxidative processes, metabolism, and epigenetic regulation in selected experimental models. Overall, evidence linking BPA exposure to ovarian-cancer-related outcomes remains limited, and current findings do not establish that BPA causes OC or worsens patient prognosis in humans.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.